630103-34-3

Upstream product

• 624-92-0 Dimethyldisulphide 
• 630103-32-1 (1'R,2'S,4'S,5'S)-4-(2-amino-6-chloro-9H-purin-9-yl)-1-[(dibenzylphosphato)methyl]-2-(dibenzyloxyphosphato)bicyclo[3.1.0]hexane 
• 630103-30-9 (1'R,2'S,4'S,5'S)-4-(2-amino-6-chloro-9H-purin-9-yl)-1-(benzyloxymethyl)-2-benzyloxybicyclo[3.1.0]hexane 
• 630103-31-0 (1'R,2'S,4'S,5'S)-4-(2-amino-6-chloro-9H-purin-9-yl)-1-(hydroxymethyl)-2-hydroxybicyclo[3.1.0]hexane 
• 259659-49-9 (1S,2R,4S,5R)-4-(phenylmethoxy)-5-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexan-2-ol 
• 10310-21-1 2-Amino-6-chloropurin 
• 108549-23-1 Dibenzyl N,N-diisopropylphosphoramidite 

Downstream Products

• 630103-36-5 (1'R,2'S,4'S,5'S)-4-(6-methylamino-2-methylthio-9H-purin-9-yl)-1-[(dibenzylphosphato)methyl]-2-(dibenzyloxyphosphato)-bicyclo[3.1.0]hexane 

Relevant academic research and scientific papers

2-Substitution of Adenine Nucleotide Analogues containing a Bicyclo[3.1.0]hexane Ring System Locked in a Northern Conformation: Enhanced Potency as P2Y1 Receptor Antagonists

Preference for the northern (N) ring conformation of the ribose moiety of adenine nucleotide 3′,5′-bisphosphate antagonists of P2Y 1 receptors was established by using a ring-constrained methanocarba (a bicyclo[3.1.0]hexane) ring as a ribose su